title: Thiazolidinedione inhibits production of RANTES in a cytokine-treated human lung epithelial cell line.
abstract: The chemokine RANTES is a potent chemoattractant for eosinophils. RANTES is produced by lung epithelial cells during eosinophil-rich inflammatory diseases such as asthma. In this study, we examined the effects of thiazolidinediones (TZD) on RANTES expression in a human lung epithelial cell line, A549. In A549 cells, interleukin-1beta and tumor necrosis factor-alpha induced endogenous RANTES protein secretion, mRNA expression, and promoter activity. The TZD inhibited these effects. Our data indicate that the suppression of the expression of RANTES can be accomplished by TZD treatment, raising the possibility that TZD might be of therapeutic value in diseases such as asthma.
authors.affiliation: First Department of Internal Medicine, Kagawa Medical University, Kita-gun, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Momoi
authors.forename: K
authors.initials: K
authors.lastname: Murao
authors.forename: H
authors.initials: H
authors.lastname: Imachi
authors.forename: Y
authors.initials: Y
authors.lastname: Sayo
authors.forename: H
authors.initials: H
authors.lastname: Nakamura
authors.forename: H
authors.initials: H
authors.lastname: Hosokawa
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: J
authors.initials: J
authors.lastname: Fujita
authors.forename: H
authors.initials: H
authors.lastname: Okada
authors.forename: T
authors.initials: T
authors.lastname: Ishida
authors.forename: J
authors.initials: J
authors.lastname: Takahara
mesh_terms: D002460:Cell Line; D018946:Chemokine CCL5 / Q000096:biosynthesis / Q000235:genetics*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D004804:Eosinophils / Q000187:drug effects / Q000502:physiology*; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D006967:Hypersensitivity / Q000097:blood; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000494:pharmacology; D008156:Luciferases / Q000235:genetics; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D011994:Recombinant Proteins / Q000096:biosynthesis; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D014158:Transcription, Genetic / Q000187:drug effects; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D018946:Chemokine CCL5; D007375:Interleukin-1; D011743:Pyrimidines; D012333:RNA, Messenger; D011994:Recombinant Proteins; D013844:Thiazoles; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D003907:Dexamethasone; C006253:pirinixic acid; C089946:2,4-thiazolidinedione; D008156:Luciferases